Research Library

Despite recent claims that “free trade is dead,” fellow Simon Lester explains that America was never close to anything resembling free trade in the first place. Instead, current U.S. trade policy, just like past policy, reflects a messy mix of free market and industrial policy views.

Drug companies that bypass distributors and offer generics directly to patients, like the Mark Cuban Cost Plus Drug Company, could disrupt the pharmaceutical supply chain and ultimately save thousands of lives.

With the recent enactment of the CHIPS and Science Act, the conversation about industrial policy has started up again. Are state-directed economic policies back, and will such initiatives work?

Mark Finley reviews the 2022 edition of the bp Statistical Review of World Energy.

Though the OPEC+ group has agreed to accelerate planned oil production increases, the move will likely do little to reduce prices at the pump, despite a major U.S. concession, writes author Mark Finley — and Russia appears to support the plan. Read more on the Baker Institute Blog.   This article originally appeared in the Forbes blog on June 6, 2022.

"Creating a global norm for PPA transparency is a zero-cost step to help provide energy for everyone and deliver on the low carbon future we all need," write the authors. Read their post about power purchase agreements on the Baker Institute Blog.  This article originally appeared in the Forbes blog on June 1, 2022.

The Saudi leadership has repeatedly rebuffed requests from President Biden and leaders of oil-importing countries to accelerate production increases. But recent price differentials could signal an intent to quietly steer crude into Europe to replace Russian supplies, writes the author. Read the post on the Baker Institute Blog.  This article originally appeared in the Forbes blog on May 4, 2022.